Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;106:1465-1469
Published online before print September 3, 2002, doi: 10.1161/01.CIR.0000029745.63708.E9
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
106/12/1465    most recent
01.CIR.0000029745.63708.E9v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Lorgeril, M.
Right arrow Articles by de Leiris, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Lorgeril, M.
Right arrow Articles by de Leiris, J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ETHANOL
Medline Plus Health Information
*Heart Attack
Related Collections
Right arrow Secondary prevention

(Circulation. 2002;106:1465.)
© 2002 American Heart Association, Inc.


Clinical Investigation and Reports

Wine Drinking and Risks of Cardiovascular Complications After Recent Acute Myocardial Infarction

Michel de Lorgeril, MD; Patricia Salen, BSc; Jean-Louis Martin, PhD; François Boucher, PhD; François Paillard, MD; Joël de Leiris, PhD

From the Laboratoire du Stress Cardiovasculaire et Pathologies Associées, Université Joseph Fourier de Grenoble, France (M.d.L., P.S., F.B., J.d.L.); Unité d’Epidémiologie de l’INRETS, Lyon, France (J.L.M.); and Département de Cardiologie, CHU-Hôpital Pontchaillou, Rennes, France (F.P.).

Correspondence to Dr M de Lorgeril, Laboratoire du Stress Cardiovasculaire et Pathologies Associées, UFR de Médecine et Pharmacie, Domaine de la Merci, 38706 La Tronche (Grenoble), France. E-mail michel.delorgeril{at}ujf-grenoble.fr

Background— Scientific data on the clinical impact of moderate alcohol consumption after a recent acute myocardial infarction (AMI) are limited, and the specific effect of wine ethanol has not been studied.

Methods and Results— In survivors of a recent AMI, we analyzed the association between ethanol intake and the risk of recurrence. The patients were classified according to the amount of ethanol that they consumed regularly during follow-up. Major prognostic factors, including the severity of the prior AMI and drug treatment, were recorded and included in the analyses. Only patients with at least 2 reliable assessments of drinking (and dietary) habits were included (n=437). The average ethanol intake was 7.6% of the total energy intake, wherein wine ethanol represented 92% of the total. Among these patients, 104 cardiovascular complications occurred during a mean follow-up period of 4 years. In comparison with abstainers, the adjusted risk of complications was reduced by 59% (95% confidence interval: 17 to 80) in patients whose average ethanol intake was 7.7% of the total energy intake (about 2 drinks/day), and by 52% (95% confidence interval: 4 to 76) in those whose average ethanol intake was of 16% of energy (about 4 drinks/day).

Conclusion— Whereas moderate wine drinking was associated with a significant reduction in the risk of complications in this homogenous population of coronary heart disease patients, further studies are required to confirm the data, define the clinical and biological profile of the patients who would most benefit from wine drinking after recent AMI, and examine whether the relations found are due to ethanol or other wine ingredients.


Key Words: alcohol • coronary disease • myocardial infarction • prevention • diet




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
R. di Giuseppe, M. de Lorgeril, P. Salen, F. Laporte, A. Di Castelnuovo, V. Krogh, A. Siani, J. Arnout, F. P Cappuccio, M. van Dongen, et al.
Alcohol consumption and n-3 polyunsaturated fatty acids in healthy men and women from 3 European populations
Am. J. Clinical Nutrition, January 1, 2009; 89(1): 354 - 362.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
R. Corder
Red wine, chocolate and vascular health: developing the evidence base
Heart, July 1, 2008; 94(7): 821 - 823.
[Full Text] [PDF]


Home page
Eur Heart JHome page
M. de Lorgeril, P. Salen, T. Corcos, P. Defaye, M. Juneau, B. Pavy, and N. Saoudi
Is moderate drinking as effective as cholesterol lowering in reducing mortality in high-risk coronary patients?
Eur. Heart J., January 1, 2008; 29(1): 4 - 6.
[Full Text] [PDF]


Home page
Eur Heart JHome page
I. Janszky, R. Ljung, S. Ahnve, J. Hallqvist, A. M. Bennet, and K. J. Mukamal
Alcohol and long-term prognosis after a first acute myocardial infarction: the SHEEP study
Eur. Heart J., January 1, 2008; 29(1): 45 - 53.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. J. Ignarro, M. L. Balestrieri, and C. Napoli
Nutrition, physical activity, and cardiovascular disease: An update
Cardiovasc Res, January 15, 2007; 73(2): 326 - 340.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
K. J. Mukamal, S. E. Chiuve, and E. B. Rimm
Alcohol consumption and risk for coronary heart disease in men with healthy lifestyles.
Arch Intern Med, October 23, 2006; 166(19): 2145 - 2150.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. de Leiris, M. de Lorgeril, and F. Boucher
Ethanol and cardiac function
Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1027 - H1028.
[Full Text] [PDF]


Home page
CirculationHome page
K. J. Mukamal, M. Maclure, J. E. Muller, and M. A. Mittleman
Binge Drinking and Mortality After Acute Myocardial Infarction
Circulation, December 20, 2005; 112(25): 3839 - 3845.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. E. Szmitko and S. Verma
Antiatherogenic potential of red wine: clinician update
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2023 - H2030.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
G. Anstadt
Modifiable Behavioral Factors as Causes of Death
JAMA, June 23, 2004; 291(24): 2941 - 2941.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. Aguilar, H. Skali, L. A. Moye, E. F. Lewis, J. M. Gaziano, J. D. Rutherford, L. H. Hartley, O. S. Randall, E. M. Geltman, G. A. Lamas, et al.
Alcohol consumption and prognosis in patients with left ventricular systolic dysfunction after a myocardial infarction
J. Am. Coll. Cardiol., June 2, 2004; 43(11): 2015 - 2021.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M de Lorgeril and P Salen
Is alcohol anti-inflammatory in the context of coronary heart disease?
Heart, April 1, 2004; 90(4): 355 - 357.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M N Zairis, J A Ambrose, A G Lyras, M A Thoma, P K Psarogianni, P G Psaltiras, A D Kardoulas, G P Bibis, E G Pissimissis, P C Batika, et al.
C Reactive protein, moderate alcohol consumption, and long term prognosis after successful coronary stenting: four year results from the GENERATION study
Heart, April 1, 2004; 90(4): 419 - 424.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Bohm, S. Rosenkranz, and U. Laufs
Alcohol and red wine: impact on cardiovascular risk
Nephrol. Dial. Transplant., January 1, 2004; 19(1): 11 - 16.
[Full Text] [PDF]